The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
US9162991, 4d ID: ALA3893064
PubChem CID: 25015312
Max Phase: Preclinical
Molecular Formula: C18H13N5O5
Molecular Weight: 379.33
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(/C=C/c1ccc([N+](=O)[O-])cc1)c1cn(Cc2ccc([N+](=O)[O-])cc2)nn1
Standard InChI: InChI=1S/C18H13N5O5/c24-18(10-5-13-1-6-15(7-2-13)22(25)26)17-12-21(20-19-17)11-14-3-8-16(9-4-14)23(27)28/h1-10,12H,11H2/b10-5+
Standard InChI Key: CVKOJPBBOPIMAL-BJMVGYQFSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5956 -2.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6003 1.4977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8990 0.7455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.2526 1.3618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.2524 0.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.4979 -1.0529 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.0317 -0.7359 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.7433 0.3919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.2371 1.4856 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-8.6194 -0.8266 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.1129 -0.6780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.9891 -1.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.4819 -1.7502 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.3552 -2.9699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.7355 -4.3359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-11.2427 -4.4823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.3695 -3.2627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-13.6067 -5.5580 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-13.1095 -6.6501 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-14.8012 -5.4430 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
11 14 1 0
14 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
21 24 1 0
24 25 1 0
24 26 2 0
7 27 1 0
27 28 2 0
28 4 1 0
M CHG 4 1 -1 2 1 24 1 25 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.33Molecular Weight (Monoisotopic): 379.0917AlogP: 3.04#Rotatable Bonds: 7Polar Surface Area: 134.06Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.93CX LogD: 3.93Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.27Np Likeness Score: -1.28
References 1. (2015) Cinnamoyl inhibitors of transglutaminase, 2. Apperley KYP, Roy I, Saucier V, Brunet-Filion N, Piscopo SP, Pardin C, De Francesco É, Hao C, Keillor JW.. (2017) Development of new scaffolds as reversible tissue transglutaminase inhibitors, with improved potency or resistance to glutathione addition., 8 (2): [PMID:30108749 ] [10.1039/C6MD00565A ]